Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum

被引:19
作者
Daniel, EE
Anvari, M
Fox-Threlkeld, JET
McDonald, TJ
机构
[1] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Surg, Hamilton, ON L8N 3Z5, Canada
[3] McMaster Univ, Sch Nursing, Hamilton, ON L8N 3Z5, Canada
[4] Univ Western Ontario, Dept Med, London, ON N6A SA5, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2002年 / 283卷 / 03期
关键词
gastric emptying; intestinal motility; capsaicin; afferent nerves; paracrine action;
D O I
10.1152/ajpgi.00110.2002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Glucagon-like peptide-1 (GLP-1) modulates glucose levels following a meal, including by inhibition of gastric emptying and intestinal transport. Intra-arterial injection of GLP-1 into the gastric corpus, antrum, or pylorus of anesthetized dogs had no effect on the contractile activity of the resting or neurally activated stomach. GLP-1 injected intra-arterially inhibited intestinal segments when activated by enteric nerve stimulation but not by acetylcholine. Isolated ileum segments were perfused intra-arterially, instrumented with strain gauges to record circular muscle activity and with subserosal electrodes to stimulate enteric nerves. GLP-1 caused concentration-dependent inhibition of nerve-stimulated phasic but not tonic activity. This was absent during TTX-induced activity and partly prevented by N-G-nitro-L-arginine. Exendin-(9-39), the GLP-1 antagonist, had no intrinsic activity and did not affect the actions of GLP-1. Capsaicin mimicked the effects of GLP-1 and may have reduced the effect of subsequent GLP-1. GLP-1 may mediate paracrine action on afferent nerves in the canine ileal mucosa using an unusual receptor.
引用
收藏
页码:G595 / G602
页数:8
相关论文
共 73 条
[1]   Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice [J].
Ahrén, B ;
Holst, JJ ;
Mårtensson, H ;
Balkan, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (1-2) :239-245
[2]   EXTRINSIC AND INTRINSIC NEURAL CONTROL OF PYLORIC SPHINCTER PRESSURE IN THE DOG [J].
ALLESCHER, HD ;
DANIEL, EE ;
DENT, J ;
FOX, JET ;
KOSTOLANSKA, F .
JOURNAL OF PHYSIOLOGY-LONDON, 1988, 401 :17-38
[3]   Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat [J].
Anini, Y ;
Fu-Cheng, XM ;
Cuber, JC ;
Kervran, A ;
Chariot, J ;
Rozé, C .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1999, 438 (03) :299-306
[4]   Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid [J].
Anvari, M ;
Paterson, CA ;
Daniel, EE ;
McDonald, TJ .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (06) :1133-1140
[5]   Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice [J].
Baggio, L ;
Kieffer, TJ ;
Drucker, DJ .
ENDOCRINOLOGY, 2000, 141 (10) :3703-3709
[6]   Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats [J].
Balkan, B ;
Kwasnik, L ;
Miserendino, R ;
Holst, JJ ;
Li, X .
DIABETOLOGIA, 1999, 42 (11) :1324-1331
[7]   Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide [J].
Blázquez, E ;
Alvarez, E ;
Roncero, I ;
Rodríguez-Fonseca, F ;
Chowen, JA ;
Zueco, JA .
MOLECULAR NEUROBIOLOGY, 1998, 18 (02) :157-173
[8]   COEXISTENCE OF GLICENTIN AND PEPTIDE-YY IN COLORECTAL L-CELLS IN CAT AND MAN - AN ELECTRON-MICROSCOPIC STUDY [J].
BOTTCHER, G ;
ALUMETS, J ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1986, 13 (3-4) :283-291
[9]   Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1 [J].
Burcelin, R ;
Dolci, W ;
Thorens, B .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (02) :252-258
[10]   DIVERGENT TISSUE-SPECIFIC AND DEVELOPMENTAL EXPRESSION OF RECEPTORS FOR GLUCAGON AND GLUCAGON-LIKE PEPTIDE-1 IN THE MOUSE [J].
CAMPOS, RV ;
LEE, YC ;
DRUCKER, DJ .
ENDOCRINOLOGY, 1994, 134 (05) :2156-2164